AnaptysBio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $30,017 | $10,971 | $7,179 | $9,005 |
Gross Profit | 29,421 | 10,376 | 6,574 | 8,401 |
EBITDA | -16,842 | -35,103 | -37,014 | -36,653 |
EBIT | -17,438 | -35,698 | -37,619 | -37,257 |
Net Income | -32,851 | -46,660 | -43,936 | -42,211 |
Net Change In Cash | 30,017 | 10,971 | 7,179 | 9,005 |
Free Cash Flow | -10,125 | -14,415 | -44,220 | -34,629 |
Cash | 191,581 | 71,821 | 53,695 | 35,965 |
Basic Shares | 28,893 | 27,356 | 26,801 | 26,586 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $17,157 | $10,287 | $63,175 | $75,000 |
Gross Profit | 14,781 | 7,952 | -35,321 | -5,025 |
EBITDA | -143,164 | -105,257 | -55,706 | -19,372 |
EBIT | -145,540 | -107,592 | -57,795 | -19,931 |
Net Income | -163,619 | -128,724 | -57,193 | -19,920 |
Net Change In Cash | 17,157 | 10,287 | 63,175 | 75,000 |
Cost of Revenue | -424,421 | 245,213 | 79,439 | |
Free Cash Flow | -121,607 | -73,951 | -47,286 | -14,726 |
Cash | 35,965 | 71,308 | 495,729 | 250,456 |
Basic Shares | 26,924 | 28,165 | 27,431 | 27,302 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.14 |
2024-06-30 | -$1.71 |
2024-03-31 | -$1.64 |
2023-12-31 | -$1.59 |
